Abstract

Tuberculosis (TB) continues to be a major global health challenge in the 21st century, with millions affected annually. While progress has been made in the treatment and management of TB, the disease remains a leading cause of death worldwide. The emergence of drug-resistant strains, delays in diagnosis, and the burden of TB in low- and middle-income countries exacerbate the global TB crisis. However, recent breakthroughs in diagnostic tools, new drug therapies, and vaccine development are offering hope for better treatment outcomes. This article explores the current challenges in TB treatment and highlights the innovative approaches and breakthroughs that could reshape the future of TB care, emphasizing the need for continued research and global cooperation in tackling this persistent threat.